The FDA has approved over a dozen ZYN nicotine pouches, allowing them to remain on the market. Though deemed safer for adult smokers, public health advocates express concern about their potential appeal to youth. The agency stresses that nicotine pouches are not without risk, and emphasizes the importance of limiting youth access. The decision comes as part of a broader strategy to revise tobacco product regulations, including a proposed nicotine cap to reduce addiction. While ZYN provides an alternative for quitting smoking, the FDA cautions it does not endorse the safety of these products.